Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iwanaga, Y.
Right arrow Articles by Jeang, K.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iwanaga, Y.
Right arrow Articles by Jeang, K.-T.
[Cancer Research 62, 2618-2624, May 1, 2002]
© 2002 American Association for Cancer Research


Regular Articles

Expression of Mitotic Spindle Checkpoint Protein hsMAD1 Correlates with Cellular Proliferation and Is Activated by a Gain-of-Function p53 Mutant

Yoichi Iwanaga and Kuan-Teh Jeang1

Molecular Virology Section, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892-0460

Human mitotic arrest deficiency protein 1, hsMAD1, is a component of the mitotic spindle assembly checkpoint (MSC) that monitors fidelity of chromosomal segregation and guards against emergence of cellular aneuploidy. Because aneuploidy is a pervasive characteristic of human cancers, understanding how MSC genes are regulated is important. Here, we have analyzed human genomic sequences upstream of the 5' most hsMAD1 coding exon and have identified a 1.5-kb fragment with promoter activity. The hsMad1 promoter, consistent with characteristics of housekeeping genes, is highly GC rich and is devoid of a TATA-box. Mutational analyses revealed a core region spanning -73 to -31 as being essential for hsMad1 transcription. Surprisingly, although MSC function, prototypically induced by microtubule inhibitors, is active selectively during mitosis, we found the hsMad1 promoter to be expressed predominantly in G1 and to respond not to microtubule inhibitor but to mitogenic stimulus. In primary, as well as transformed cells, intracellular levels of hsMAD1 correlated with the proliferative status of cells. The hsMad1 promoter was also activated preferentially by a gain-of-function p53 mutant. Taken together, our results suggest that hsMAD1 might link p53 function to the generation of cellular aneuuploidy and that heightened activation of hsMad1 by gain-of-function p53 mutants could contribute to the worse prognosis of certain cancers.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y.-C. Shen, F.-C. Hu, Y.-M. Jeng, Y.-T. Chang, Z.-Z. Lin, M.-C. Chang, C. Hsu, and A.-L. Cheng
Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer: Correlation with Clinicopathologic Features and Patient Survival
Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. M.-F. Sze, Y.-P. Ching, D.-Y. Jin, and I. O.-L. Ng
Role of a Novel Splice Variant of Mitotic Arrest Deficient 1 (MAD1), MAD1{beta}, in Mitotic Checkpoint Control in Liver Cancer
Cancer Res., November 15, 2008; 68(22): 9194 - 9201.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Mizuarai, K. Yamanaka, and H. Kotani
Mutant p53 Induces the GEF-H1 Oncogene, a Guanine Nucleotide Exchange Factor-H1 for RhoA, Resulting in Accelerated Cell Proliferation in Tumor Cells.
Cancer Res., June 15, 2006; 66(12): 6319 - 6326.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Tabakin-Fix, I. Azran, Y. Schavinky-Khrapunsky, O. Levy, and M. Aboud
Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications
Carcinogenesis, April 1, 2006; 27(4): 673 - 681.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Zhang, M. Li, W. Ma, Y. Hou, Y.-H. Li, S.-W. Li, Q.-Y. Sun, and W.-H. Wang
Localization of Mitotic Arrest Deficient 1 (MAD1) in Mouse Oocytes During the First Meiosis and Its Functions as a Spindle Checkpoint Protein
Biol Reprod, January 1, 2005; 72(1): 58 - 68.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S.-J. Jeong, H.-J. Shin, S.-J. Kim, G.-H. Ha, B.-I. Cho, K.-H. Baek, C.-M. Kim, and C.-W. Lee
Transcriptional Abnormality of the hsMAD2 Mitotic Checkpoint Gene Is a Potential Link to Hepatocellular Carcinogenesis
Cancer Res., December 1, 2004; 64(23): 8666 - 8673.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. S. Chun and D.-Y. Jin
Transcriptional Regulation of Mitotic Checkpoint Gene MAD1 by p53
J. Biol. Chem., September 26, 2003; 278(39): 37439 - 37450.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.